Clinical Trials Directory

Trials / Conditions / Stage IIIA Ovarian Epithelial Cancer

Stage IIIA Ovarian Epithelial Cancer

11 registered clinical trials studyying Stage IIIA Ovarian Epithelial Cancer.

StatusTrialSponsorPhase
CompletedMetformin and Chemotherapy in Treating Patients With Stage III-IV Ovarian, Fallopian Tube, or Primary Peritone
NCT02122185
University of ChicagoPhase 2
WithdrawnPalliative Care in Improving Quality of Life and Symptoms in Patients With Stage III-IV Pancreatic or Ovarian
NCT01927393
City of Hope Medical CenterN/A
CompletedSurvivorship Care Planning in Improving Quality of Life in Survivors of Ovarian Cancer
NCT02082470
City of Hope Medical CenterN/A
WithdrawnVaccine Therapy and IDO1 Inhibitor INCB024360 in Treating Patients With Epithelial Ovarian, Fallopian Tube, or
NCT01982487
Roswell Park Cancer InstitutePhase 1 / Phase 2
CompletedFamily Caregiver Palliative Care Intervention in Supporting Caregivers of Patients With Stage II-IV Gastrointe
NCT01846520
City of Hope Medical CenterN/A
CompletedSirolimus and Vaccine Therapy in Treating Patients With Stage II-IV Ovarian Epithelial, Fallopian Tube, or Pri
NCT01536054
Roswell Park Cancer InstitutePhase 1
CompletedPsychosexual Intervention in Patients With Stage I-III Gynecologic or Breast Cancer
NCT01764802
Ohio State University Comprehensive Cancer CenterPhase 2
CompletedSunitinib Malate in Treating Patients With Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal
NCT00388037
National Cancer Institute (NCI)Phase 2
CompletedPhase I Study of Intravenous Triapine (IND # 68338) in Combination With Pelvic Radiation Therapy With or Witho
NCT00335998
National Cancer Institute (NCI)Phase 1
CompletedCisplatin and Flavopiridol in Treating Patients With Advanced Ovarian Epithelial Cancer or Primary Peritoneal
NCT00083122
National Cancer Institute (NCI)Phase 2
CompletedErlotinib in Treating Patients With Advanced Non-Small Cell Lung Cancer, Ovarian Cancer, or Squamous Cell Carc
NCT00063895
National Cancer Institute (NCI)Phase 1 / Phase 2